ECDC and EMA Issue Advice on Fourth Doses of mRNA COVID-19 Vaccines - BioPharm International

ECDC and EMA have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines in the general population.

The European Centre for Disease Prevention and Control (ECDC) and the European Medicine Agencys (EMAs) COVID-19 task force (ETC) have concluded that it is too early to consider using a fourth dose of… [+975 chars]

full article...